AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+14.65%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$10.2B
AUM Growth
+$1.36B
(+15%)
Cap. Flow
+$223M
Cap. Flow
% of AUM
2.18%
Top 10 Holdings %
Top 10 Hldgs %
41.78%
Holding
993
New
160
Increased
390
Reduced
300
Closed
137
Top Buys
| 1 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$70.1M |
| 2 |
Enterprise Products Partners
EPD
|
$46.5M |
| 3 |
Universal Display
OLED
|
$27.4M |
| 4 |
First Solar
FSLR
|
$25.1M |
| 5 |
Array Technologies
ARRY
|
$24.6M |
Top Sells
| 1 |
TCP
TC Pipelines LP
TCP
|
$179M |
| 2 |
Caterpillar
CAT
|
$45.7M |
| 3 |
Wolfspeed
WOLF
|
$38.4M |
| 4 |
Energy Transfer Partners
ET
|
$37.5M |
| 5 |
NGL Energy Partners
NGL
|
$30.5M |
Sector Composition
| 1 | Energy | 49.58% |
| 2 | Financials | 10.59% |
| 3 | Technology | 7.31% |
| 4 | Healthcare | 5.04% |
| 5 | Industrials | 4.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
401
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $952K | 0.01% |
6,250
+761
| +14% | +$116K |
|
|
ALXN
402
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $952K | 0.01% |
6,226
-1,029
| -14% | -$157K |
|
403
Altimmune
ALT
$334M
| $950K | 0.01% |
67,200
+7,725
| +13% | +$109K |
|
404
A.O. Smith
AOS
$10.3B
| $919K | 0.01% |
13,594
+3,916
| +40% | +$265K |
|
405
Crinetics Pharmaceuticals
CRNX
$3.35B
| $910K | 0.01% |
59,563
+126
| +0.2% | +$1.93K |
|
406
XBiotech
XBIT
$89M
| $909K | 0.01% |
52,932
+534
| +1% | +$9.17K |
|
407
Monolithic Power Systems
MPWR
$41.5B
| $907K | 0.01% |
2,568
-402
| -14% | -$142K |
|
408
Entegris
ENTG
$12.4B
| $897K | 0.01% |
8,016
-1,745
| -18% | -$195K |
|
409
Geron
GERN
$893M
| $888K | 0.01% |
561,717
+545
| +0.1% | +$862 |
|
410
Starwood Property Trust
STWD
$7.56B
| $885K | 0.01% |
35,756
-5,292
| -13% | -$131K |
|
411
Cartesian Therapeutics
RNAC
$277M
| $884K | 0.01% |
6,515
+120
| +2% | +$16.3K |
|
|
WRK
412
DELISTED
WestRock Company
WRK
| $880K | 0.01% |
16,907
-3,047
| -15% | -$159K |
|
413
FNB Corp
FNB
$5.92B
| $878K | 0.01% |
69,142
-10,230
| -13% | -$130K |
|
|
GMDA
414
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $866K | 0.01% |
107,107
+17,686
| +20% | +$143K |
|
415
89bio
ETNB
$1.32B
| $852K | 0.01% |
35,959
+28
| +0.1% | +$663 |
|
416
EPAM Systems
EPAM
$9.44B
| $850K | 0.01% |
2,141
-164
| -7% | -$65.1K |
|
|
PGRE
417
Paramount Group
PGRE
$1.66B
| $847K | 0.01% |
83,632
-12,376
| -13% | -$125K |
|
418
Graco
GGG
$14.2B
| $841K | 0.01% |
11,742
+3,201
| +37% | +$229K |
|
|
AAT
419
American Assets Trust
AAT
$1.28B
| $840K | 0.01% |
25,904
-3,834
| -13% | -$124K |
|
420
Viking Therapeutics
VKTX
$3.03B
| $835K | 0.01% |
131,978
+469
| +0.4% | +$2.97K |
|
421
Aldeyra Therapeutics
ALDX
$334M
| $834K | 0.01% |
70,227
+1,057
| +2% | +$12.6K |
|
|
SYRS
422
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $834K | 0.01% |
11,151
+2,880
| +35% | +$215K |
|
423
Douglas Emmett
DEI
$2.83B
| $780K | 0.01% |
24,851
-4,518
| -15% | -$142K |
|
424
Crown Castle
CCI
$41.9B
| $778K | 0.01% |
4,522
+495
| +12% | +$85.2K |
|
425
Cintas
CTAS
$82.4B
| $777K | 0.01% |
9,108
-588
| -6% | -$50.2K |
|